For example, in the AD rodent model of APPPS1 mice, the lack of neuroinflammation-related gene TREM2 expression (i.e., TREM2 deficiency) lowered amyloid pathologies at the earlier stage of disease development but worsened it at the later stage. This evidence concerns the gene TREM2 and Alzheimer disease.